Literature DB >> 22478854

The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders.

David B Nash, Michael Toscani, F Randy Vogenberg.   

Abstract

Although biologics are a growing area of interest, payers, purchasers, and providers understand surprisingly little about their overall costs or benefits coverage.

Year:  2011        PMID： 22478854      PMCID： PMC3138381     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  3 in total

1.  Needed: a new business model.

Authors:  F Randy Vogenberg
Journal:  Biotechnol Healthc       Date:  2011

2.  The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.

Authors:  David B Nash; Michael Toscani; F Randy Vogenberg
Journal:  Biotechnol Healthc       Date:  2011

3.  Beyond the cost of biologics: employer survey reveals gap in understanding role of specialty pharmacy and benefit design.

Authors:  F Randy Vogenberg; Cheryl Larson; Margaret Rehayem; Larry Boress
Journal:  Am Health Drug Benefits       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.